2013
DOI: 10.1515/cclm-2013-0142
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of vancomycin in human serum by LC-MS/MS

Abstract: Background: The aim of our work was to develop and validate a reliable LC-MS/MS-based measurement procedure for the quantification of vancomycin in serum, to be applied in the context of efforts to standardize and harmonize therapeutic drug monitoring of this compound using routine assays. Methods: Sample preparation was based on protein precipitation followed by ultrafiltration. In order to minimize differential modulation of ionization by matrix constituents extended chromatographic separation was applied le… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
39
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(42 citation statements)
references
References 12 publications
(18 reference statements)
1
39
0
Order By: Relevance
“…Also, it is well known that some immunoassay methods are prone to interference by paraproteins or rheumatic factor (18) or can cross-react with crystalline degradation products, which comprise inactive metabolites of vancomycin found in plasma or serum samples from renally impaired and dialysis patients (19)(20)(21). As LC-MS/MS methods are more specific, it is generally accepted that they are less likely to suffer from these issues (22). Differences in unbound vancomycin concentrations between immunoassays and HPLC were recently illustrated in a study by Crandon et al in which unbound vancomycin concentrations were measured by an FPIA and an in-house-developed HPLC method (9).…”
Section: Discussionmentioning
confidence: 99%
“…Also, it is well known that some immunoassay methods are prone to interference by paraproteins or rheumatic factor (18) or can cross-react with crystalline degradation products, which comprise inactive metabolites of vancomycin found in plasma or serum samples from renally impaired and dialysis patients (19)(20)(21). As LC-MS/MS methods are more specific, it is generally accepted that they are less likely to suffer from these issues (22). Differences in unbound vancomycin concentrations between immunoassays and HPLC were recently illustrated in a study by Crandon et al in which unbound vancomycin concentrations were measured by an FPIA and an in-house-developed HPLC method (9).…”
Section: Discussionmentioning
confidence: 99%
“…Various analytical methods have been developed for measuring vancomycin in liquid samples only, such as plasma/serum, urine, human drainage tissue fluid and bronchoalveolar lavage fluid, including HPLC methods [8][9][10] and LC-MS/MS methods [11][12][13][14][15]. A few methods have been reported for the determination of vancomycin in both liquid and solid samples, such as immunoassays for plasma/serum and bone [16,17], HPLC method for plasma, bone and atrial appendage tissue [18], and LC-MS/MS for serum, perivascular fat and atrial wall samples [19].…”
Section: Introductionmentioning
confidence: 99%
“…The current UHPLC-MS/MS method is superior to the PETINIA technique as it requires only 2 µL of sample compared to the large volumes (50 µL to fill the sample cuvette) required by the immunoassay. Other LC-MS/MS assays determined VAN in human [8] or rat plasma [7], and human serum [6].…”
Section: Resultsmentioning
confidence: 99%
“…There are several methodologies available for the measurements of VAN in biological matrices that include radioimmunoassays, fluorescence immunoassays, fluorescence polarization immunoassays [3], particle enhanced turbidimetric inhibition immunoassays (PETINIA) [4], liquid chromatography (LC) [5], and LC-tandem mass spectrometry (LC-MS/MS) [6] [7] [8] [9]. These methods were successfully used to measure VAN in a variety of matrices, but they had their limitations.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation